Alto Neuroscience, Inc. - Common Stock, par value $0.0001 per share (ANRO)

CUSIP: 02157Q109

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
31,755,000
Total 13F shares
26,830,701
Share change
+2,359,630
Total reported value
$602,479,913
Put/Call ratio
3.4%
Price per share
$22.48
Number of holders
110
Value change
+$54,953,807
Number of buys
48
Number of sells
52

Quarterly Holders Quick Answers

What is CUSIP 02157Q109?
CUSIP 02157Q109 identifies ANRO - Alto Neuroscience, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ANRO - Alto Neuroscience, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Commodore Capital LP
13D/G 13F
Company
9.9%
3,588,180
$77,791,742 +$7,426,527 31 Mar 2026
Alpha Wave Global, LP
13F 3/4/5
Company · 10%+ Owner
12%
3,707,757
$65,998,075 31 Dec 2025
Point72 Asset Management, L.P.
13F 13D/G
Company · Steven A. Cohen
3.7%
from 13D/G
4,432,453
mixed-class rows
$64,883,188 31 Dec 2025
BlackRock, Inc.
13F 13D/G
Company
2.1%
from 13D/G
4,468,395
mixed-class rows
$60,389,247 31 Dec 2025
Sirenia Capital Management LP
13D/G
7.9%
2,591,587
$56,185,606 $0 31 Mar 2026
VANGUARD GROUP INC
13F
Company
mixed-class rows
3,802,680
mixed-class rows
$55,601,013 31 Dec 2025
13F
PERCEPTIVE ADVISORS LLC
13D/G 13F
Company
10%
3,249,934
$53,623,911 +$20,798,926 31 Dec 2025
ARMISTICE CAPITAL, LLC
13F 13D/G
Company
4.9%
from 13D/G
3,236,000
mixed-class rows
$49,168,800 31 Dec 2025
Vestal Point Capital, LP
13D/G 13F
Company
6.5%
2,064,075
$44,749,146 -$9,125,654 31 Mar 2026
SYSTEMATIC FINANCIAL MANAGEMENT LP
13F
Company
6.1%
2,504,864
$32,162,463 31 Dec 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
mixed-class rows
1,472,533
mixed-class rows
$22,032,049 31 Dec 2025
13F
Kevin Kotler
13F
Individual
4.1%
1,713,789
$21,997,218 31 Dec 2025
13F
FRANKLIN RESOURCES INC
13F
Company
mixed-class rows
1,167,937
mixed-class rows
$20,549,418 31 Dec 2025
13F
STATE STREET CORP
13F
Company
mixed-class rows
1,403,400
mixed-class rows
$18,667,754 31 Dec 2025
13F
Vivo Capital, LLC
13F
Company
3.3%
1,035,551
$18,432,808 31 Dec 2025
13F
WEBER CAPITAL MANAGEMENT LLC /ADV
13F
Company
3.4%
1,400,149
$17,977,913 31 Dec 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
mixed-class rows
1,257,333
mixed-class rows
$17,575,396 31 Dec 2025
13F
Nuveen, LLC
13F
Company
3.1%
1,295,072
$16,628,724 31 Dec 2025
13F
ROYCE & ASSOCIATES LP
13F
Company
3.1%
1,267,451
$16,274,071 31 Dec 2025
13F
SEGALL BRYANT & HAMILL, LLC
13F
Company
2.9%
1,198,157
$15,384,336 31 Dec 2025
13F
K2 HealthVentures Equity Trust LLC
13D/G
2.4%
788,995
$13,018,418 -$13,676,190 31 Dec 2025
Bastion Asset Management Inc.
13F
Company
2.7%
1,118,180
$12,885,191 31 Dec 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
mixed-class rows
940,482
mixed-class rows
$12,558,888 31 Dec 2025
13F
NORTHERN TRUST CORP
13F
Company
mixed-class rows
779,494
mixed-class rows
$12,361,592 31 Dec 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
mixed-class rows
947,515
mixed-class rows
$12,321,333 31 Dec 2025
13F
72 Investment Holdings, LLC
13F
Company
2.1%
667,778
$11,886,448 31 Dec 2025
13F
UBS Group AG
13F
Company
mixed-class rows
748,567
mixed-class rows
$9,703,306 31 Dec 2025
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
1.8%
752,941
$9,667,762 31 Dec 2025
13F
Ikarian Capital, LLC
13F
Company
1.6%
515,000
$9,167,001 31 Dec 2025
13F
PARADIGM CAPITAL MANAGEMENT INC/NY
13F
Company
1.6%
678,200
$8,708,088 31 Dec 2025
13F
ALKEON CAPITAL MANAGEMENT LLC
13F
Company
1.5%
477,101
$8,492,398 31 Dec 2025
13F
Phocas Financial Corp.
13F
Company
1.5%
606,273
$7,784,545 31 Dec 2025
13F
Pier Capital, LLC
13F
Company
1.4%
571,855
$7,342,618 31 Dec 2025
13F
JANE STREET GROUP, LLC
13F
Company
mixed-class rows
494,941
mixed-class rows
$7,317,485 31 Dec 2025
13F
MARSHALL WACE, LLP
13F
Company
mixed-class rows
477,797
mixed-class rows
$7,092,736 31 Dec 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
mixed-class rows
472,708
mixed-class rows
$6,844,912 31 Dec 2025
13F
Integral Health Asset Management, LLC
13F
Company
1.2%
375,000
$6,675,000 31 Dec 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
mixed-class rows
445,177
mixed-class rows
$6,412,045 31 Dec 2025
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
1.1%
336,762
$5,994,364 31 Dec 2025
13F
TWO SIGMA ADVISERS, LP
13F
Company
mixed-class rows
390,101
mixed-class rows
$5,802,993 31 Dec 2025
13F
Manatuck Hill Partners, LLC
13F
Company
1%
425,000
$5,457,000 31 Dec 2025
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.96%
398,172
$5,112,528 31 Dec 2025
13F
Qube Research & Technologies Ltd
13F
Company
mixed-class rows
342,088
mixed-class rows
$4,951,859 31 Dec 2025
13F
ESSEX INVESTMENT MANAGEMENT CO LLC
13F
Company
0.87%
360,544
$4,629,385 31 Dec 2025
13F
MORGAN STANLEY
13F
Company
mixed-class rows
334,685
mixed-class rows
$4,622,639 31 Dec 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
mixed-class rows
349,970
mixed-class rows
$4,578,252 31 Dec 2025
13F
Peapod Lane Capital LLC
13F
Company
0.8%
253,992
$4,521,058 31 Dec 2025
13F
AWM Investment Company, Inc.
13F
Company
0.71%
225,000
$4,005,000 31 Dec 2025
13F
Spruce Street Capital LP
13F
Company
0.7%
222,844
$3,966,623 31 Dec 2025
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
mixed-class rows
247,823
mixed-class rows
$3,460,000 31 Dec 2025
13F

Institutional Holders of Alto Neuroscience, Inc. - Common Stock, par value $0.0001 per share (ANRO) as of Q1 2026

As of 31 Mar 2026, Alto Neuroscience, Inc. - Common Stock, par value $0.0001 per share (ANRO) was held by 110 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,830,701 shares. The largest 10 holders included Alpha Wave Global, LP, Commodore Capital LP, Vestal Point Capital, LP, PERCEPTIVE ADVISORS LLC, Spruce Street Capital LP, VANGUARD CAPITAL MANAGEMENT LLC, FRANKLIN RESOURCES INC, Vivo Capital, LLC, ARMISTICE CAPITAL, LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 110 institutional shareholders reporting positions in this security for the Q1 2026 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
96
Q1 2026 holders
110
Holder diff
14
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 Value $ Q1 2026 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .